The JNK signalling pathway is required for the tumorigenesis and metastasis of BC and is significantly activated in advanced and metastatic BC [48, 56], which could explain why phosphorylated c-Jun was enriched in advanced AJCC TNM stages of ER-positive BC in our work. This evidence concerns the gene JUN and breast cancer.